Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Physical Training Interaction
NCT03316690Completed
- Start
- Oct 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM) and impaired glucose tolerance (IGT). Primary endpoint: Mean blood glucose concentration during a 4 hour mixed-meal tolerance test at 101 days. Started Oct 2017; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT03316690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03316690.